References
- Weinstein H J, Mayer R J, Rosenthal D S, et al. Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 1983; 62: 315
- Creutzig U, Ritter J, Langermann H J, et al. Improved treatment results in childhood acute myelogenous leukemia: A report of the German cooperative study AML-BFM-78. Blood 1985; 65: 298–304
- Kantarjian H M, Keating M I, Walters R S, et al. Acute promyelocytic leukemia: The M.D. Anderson Hospital Experience. Am J Med 1986; 80: 789–797
- Cunningham I, Gee T S, Reich L M, et al. Acute promyelocytic leukemia: Treatment results during a decade at Memorial Hospital. Blood 1989; 73: 1116–1122
- Groupe francais de morphologie hematologique. French registry of acute leukemia and myelodysplastic syndromes: Age distribution and hemogram analysis of the 4496 cases recorded during 1982–1983 and classified according to FAB criteria. Cancer 1987; 60: 1385–1394
- Feldman E I, Arlin Z A, Ahmed T, et al. Acute promyelocytic leukemia: A 5 year experience with new antileukemic agents and a new approach to preventing fatal hemorrhage. Acta Haematologica 1989; 82: 117–121
- Marty M, Ganem G, Fischer J, et al. Leucemie aigue promyelocyte: Etude retrospective de 119 malades traites par daunorubicine. Nouv Rev Fr Hematol 1984; 26: 371–378
- Fourth International Workshop on Chromosomes in Leukemia 1982. Cancer Genet Cytogenet 1984; 11: 251
- Le Beau M M, Larson R A, Bitter M A, et al. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinico-pathological association. N Engl J Med 1983; 309: 630
- Rowley J D, Alimena G, Garson O M, et al. A collaborative study of the relationship of the morphological type of acute nonlym-phocytic leukemia with patient age and karyotype. Blood 1982; 59: 1013–1022
- Arlin Z A, Case D C, Wiernik P, et al. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adults with acute nonlymphocytic leukemia (ANLL). Leukemia 1990; 4: 177–183
- Feldman E J, Biguzzi S, Ahmed, et al. Preliminary experience with short course high-dose cytarabine in patients with acute leukemia and blastic phase of chronic myelogenous leukemia. Leukemia Lymphoma in press 1990
- Yamada M, Hudson S, Tournay O, et al. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-IH)-specific probes. Proc Natl Acad Sci (USA) 1989; 86: 5123–5127
- Hansen-Hagge T E, Yokota S, Bartram C R. Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor O chain sequences. Blood 1989; 74: 1762–1767
- Buchner T, Urbanitz D, Hiddemann, et al. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): Two multicenter studies of the German AML Cooperative Group. J Clin Oncol 1985; 3: 1583–1589
- Appelbaum F R, Dahlberg S, Thomas E D, et al. Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. Ann Intern Med 1984; 101: 581–588